Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin

Background: According to GLOBOCAN 2022 statistics, colorectal cancer has become the third most common cancer disease worldwide, and also the second leading cause of death. The incidence rate of rectal cancer is particularly prominent. Radiotherapy is one of the important methods for comprehensive treatment of rectal cancer, but the radiation damage caused by radiotherapy cannot be ignored. During radiotherapy for rectal cancer, the skin of the anal canal will be damaged by radiation, resulting in acute radiation dermatitis, which is characterized by redness, pain, and ulcers. The main symptom

Trial Details

NCT ID
NCT06837831
Phase
NA
Sponsor
Qianfoshan Hospital
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • Control group
  • Experimental group
Locations (sample)
  • Jinan, Shandong, China|36.66833,116.99722

Key Eligibility Criteria

  • Confirmed rectal cancer by histopathological diagnosis;
  • Individuals with clear indications for radiotherapy;
  • Individuals who receive radiation therapy for the first time and develop grade 2 or higher acute radiation dermatitis after receiving radiation the…
  • Age ≥ 18 years old;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →